A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2002
10/17/2002	WO2002080972A1 Association of a tumor antigen and a system for delivering a cytokine or a chemokine for cancer immunotherapy purposes
10/17/2002	WO2002080970A1 Method for inhibiting articular cartilage matrix calcification
10/17/2002	WO2002080968A1 Glycoprotein vi and uses thereof
10/17/2002	WO2002080962A1 Papaine containing pharmaceutical formulation resp. its use
10/17/2002	WO2002080961A1 Isolation of glycoproteins from bovine milk
10/17/2002	WO2002080960A2 Treatment of neuropathologies associated with expression of tnf-alpha
10/17/2002	WO2002080959A1 Method of treatment of hypoxia/ischaemia blutflusswiderstand
10/17/2002	WO2002080958A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/17/2002	WO2002080957A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/17/2002	WO2002080956A2 Use of compounds modulating rxr-ppar heterodimer activity as medicine for treating hepatitis c
10/17/2002	WO2002080955A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002	WO2002080954A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	WO2002080953A2 Method for reducing cellular damage resulting from hypoxia/ischaemia-related inflammation
10/17/2002	WO2002080952A2 Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
10/17/2002	WO2002080948A1 Compositions and methods for treating inflammation and related conditions
10/17/2002	WO2002080936A1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
10/17/2002	WO2002080933A1 A drug for use in bone grafting
10/17/2002	WO2002080926A1 Pyrazolopyrimidines as therapeutic agents
10/17/2002	WO2002080921A1 Composition for inhibiting hiv activity extracted from paecilomyces sp. (tochu-kaso) j300
10/17/2002	WO2002080907A1 Combination of lactacystin analog and immunosuppressive drug for the prolongation of allograft survival
10/17/2002	WO2002080894A1 Novel use of tyrosine kinase inhibitor
10/17/2002	WO2002080891A1 Use of a tnf inhibitor for the treatment of low back pain
10/17/2002	WO2002080888A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation
10/17/2002	WO2002080858A2 Use of kpv tripeptide for dermatological disorders
10/17/2002	WO2002080852A2 Genes expressed in intestinal epithelium and peyer's patch m cells
10/17/2002	WO2002080849A2 Chemotherapeutic induction of egr-1 promoter activity
10/17/2002	WO2002080848A2 Methods and materials for cancer treatment
10/17/2002	WO2002080847A2 Use of tumor necrosis factor inhibitors to treat cardiovascular disease
10/17/2002	WO2002080845A2 Novel eps8 compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080844A2 Novel bgp compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080842A2 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis
10/17/2002	WO2002080758A2 Methods for treating drug addiction
10/17/2002	WO2002080754A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions
10/17/2002	WO2002080681A1 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/17/2002	WO2002080676A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo
10/17/2002	WO2002072619A8 INTEGRIN αIIbβ3 ACTIVATING PEPTIDES AND THEIR USE
10/17/2002	WO2002068672A3 Antisense modulation of recql4 expression
10/17/2002	WO2002060933A3 Thioredoxin derived from h. pylori, which is capable of inhibiting nf-kappa b activation
10/17/2002	WO2002059140A3 Ikaros rgulatory elements and uses thereof
10/17/2002	WO2002056897A3 Pharmaceutical for stimulating the regeneration of tissues
10/17/2002	WO2002054851A3 Inhibition of pathological angiogenesis in vivo
10/17/2002	WO2002047493A3 Health promoting compositions
10/17/2002	WO2002043699A3 Preparation of large liposomes by infusion into peg
10/17/2002	WO2002043567A3 A method of treating cancer
10/17/2002	WO2002040700A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002036733A9 Cd36 as a heat shock protein receptor and uses thereof
10/17/2002	WO2002036146A3 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy
10/17/2002	WO2002036145A3 Kahalalide f formulation
10/17/2002	WO2002036108A3 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002028372A3 Systemic delivery of compounds through non-invasive bladder administration
10/17/2002	WO2002026824A3 A novel human g-protein coupled receptor, hgprbmy5, expressed highly in brain and ovarian tissues
10/17/2002	WO2002018568A3 Molecules involved in the regulation of insulin in resistance syndrome (irs)
10/17/2002	WO2002017891A3 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency
10/17/2002	WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002	WO2002010192A9 Somatostatin analogues
10/17/2002	WO2002008420A3 A method of down-regulating gene expression
10/17/2002	WO2002008260A3 Bstp-ecg1 protein and related reagents and methods of use thereof
10/17/2002	WO2002007775A3 Fusion protein for inhibition of lipoprotein secretion
10/17/2002	WO2002006457A3 Novel lipase genes
10/17/2002	WO2002002148A3 Dual recombinant gene therapy compositions and methods of use
10/17/2002	WO2002002133A3 Peptide composition for treatment of periodontal diseases and prevention of skin aging
10/17/2002	WO2002000241A3 Compositions and methods for regulating the cell cycle using a ki gene or polypeptide
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	WO2001098344A3 Angiogenesis-modulating compositions and uses
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002	WO2001074851A3 Novel proteins and nucleic acids encoding same
10/17/2002	WO2001072975A9 Human methyl transferase family member, 25552, and uses thereof
10/17/2002	WO2001060391A9 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
10/17/2002	WO2001060320A9 TREATMENT OF INFLAMMATION WITH p20
10/17/2002	WO2001059118A9 43239, a gpcr-like molecule and uses thereof
10/17/2002	WO2001059117A9 Seven-transmembrane proteins/g-protein coupled receptors
10/17/2002	WO2001059094A9 Method of regulating transcription in a cell by altering remodeling of cromatin
10/17/2002	WO2001058931A9 Method of treating disorders of the eye
10/17/2002	WO2001058922A9 Method and compositions for treating hepatocellular cancer
10/17/2002	WO2001057275A9 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
10/17/2002	WO2001055410A9 Ceramidase compositions and methods based thereon
10/17/2002	WO2001054712A9 Compositions and methods for the early diagnosis of ovarian cancer
10/17/2002	WO2001053330A9 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
10/17/2002	WO2001052878A9 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
10/17/2002	WO1998002456A3 Human c-type lectin
10/17/2002	US20020152498 Mutant plant
10/17/2002	US20020152492 Modulate gene expression
10/17/2002	US20020152486 Transgenic animal; gene therapy; genetic disorders; cardiovascular disorders
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002	US20020152481 Genetic engineering; qualitative analysis
10/17/2002	US20020152480 Alpha-synuclein super-mutants accelerate alpha-synuclein aggregation
10/17/2002	US20020152465 Method and system for providing a customized media list
10/17/2002	US20020151986 Method, Instruments,and kit for autologous tansplantation
10/17/2002	US20020151710 Fusion protein delivery system and uses thereof
10/17/2002	US20020151706 Antiinflammatory agents
10/17/2002	US20020151701 Tumor suppressor proteins; mutations; diagnosis; genetic disorders
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151692 Novel polypeptides and nucleic acids encoding same
10/17/2002	US20020151691 Class II transactivators (CIITA); major histocompatability complex; gene expression inhibition; cloning; vaccines; transcriptional promoter activity
10/17/2002	US20020151687 Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof
10/17/2002	US20020151685 Polypeptide for use in the treatment and prevention of autoimmune and allergic disease

1 ... 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 ... 3163